Geron Corp.. (GERN) NASDAQ
$3.81 (0.09) (-2.31%)
Market Cap: $2.26B
As of 05/17/24 04:00 PM EDT. Market closed.
Geron Corp.. (GERN)
NASDAQ
$3.81
(0.09) (-2.31%)
Market Cap: $2.26B
As of 05/17/24 04:00 PM EDT. Market closed.
Add to Portfolio
we are a biopharmaceutical company developing first-in-class therapies for cancer. imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. imetelstat is a potent and specific inhibitor of telomerase. based on ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
John Scarlett
Full Time Employees
291
CEO Compensation (Base)
$667,000
CEO Compensation (Total)
$2.77M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
John Scarlett
Full Time Employees
291
CEO Compensation (Base)
$667,000
CEO Compensation (Total)
$2.77M
URL
Address
919 East Hillsdale Boulevard, Suite 250, California, Foster City, 94404.
PRICE CHART FOR GERON CORP.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.91
Previous Close
$3.90
Days Range
$3.75 - $3.97
52 week range
$1.64 - $4.30
Volume
6,922,329
Avg. Volume (30 days)
9,013,724
Market Cap
$2.26B
Dividend Yield
-
P/E
(11.22)
Shares Outstanding
593,132,540
Open
$3.91
Previous Close
$3.90
Days Range
$3.75 - $3.97
52 week range
$1.64 - $4.30
Volume
6,922,329
Avg. Volume (30 days)
9,013,724
Market Cap
$2.26B
Dividend Yield
-
P/E
(11.22)
Shares Outstanding
593,132,540
FINANCIAL STATEMENTS FOR GERON CORP.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR GERON CORP.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| O'Farrell Elizabeth G. | Director | Aug 24, 2023 | Buy | $2.28 | 6,607 | 15,064 | 7,407 | Aug 24, 2023, 08:52 PM |
| O'Farrell Elizabeth G. | Director | Aug 24, 2023 | Buy | $2.28 | 6,579 | 15,000 | 26,220 | Aug 24, 2023, 08:52 PM |
| Kapur Anil | EVP, Corp Strategy & CCO | Jun 30, 2023 | Option Exercise | $2.04 | 7,567 | 15,437 | 60,783 | Jun 30, 2023, 09:18 PM |
| LAWLIS V BRYAN | Director | May 11, 2023 | Option Exercise | $1.10 | 35,000 | 38,500 | 35,000 | May 11, 2023, 09:01 PM |
| LAWLIS V BRYAN | Director | May 11, 2023 | Sale | $3.00 | 35,000 | 105,000 | 0 | May 11, 2023, 09:01 PM |
| Molineaux Susan | Director | May 01, 2023 | Option Exercise | $1.10 | 35,000 | 38,500 | 35,000 | May 01, 2023, 09:20 PM |
| Molineaux Susan | Director | May 01, 2023 | Sale | $2.48 | 35,000 | 86,800 | 0 | May 01, 2023, 09:20 PM |
| GRETHLEIN ANDREW J | EVP, Chief Operating Officer | Feb 09, 2023 | Option Exercise | $1.51 | 150,000 | 226,500 | 384,719 | Feb 10, 2023, 09:49 PM |
| GRETHLEIN ANDREW J | EVP, Chief Operating Officer | Feb 09, 2023 | Sale | $3.03 | 384,719 | 1,165,699 | 234,719 | Feb 10, 2023, 09:49 PM |
| Bloom Olivia Kyusuk | EVP, Chief Financial Officer | Feb 08, 2023 | Option Exercise | $1.51 | 400,000 | 604,000 | 474,588 | Feb 10, 2023, 09:48 PM |
| Bloom Olivia Kyusuk | EVP, Chief Financial Officer | Feb 08, 2023 | Sale | $3.08 | 400,000 | 1,232,000 | 74,588 | Feb 10, 2023, 09:48 PM |
| SCARLETT JOHN A | Chairman, President and CEO | Feb 09, 2023 | Option Exercise | $1.50 | 446,666 | 669,999 | 446,666 | Feb 10, 2023, 09:47 PM |
| SCARLETT JOHN A | Chairman, President and CEO | Feb 08, 2023 | Option Exercise | $1.50 | 446,666 | 669,999 | 446,666 | Feb 10, 2023, 09:47 PM |
| SCARLETT JOHN A | Chairman, President and CEO | Feb 10, 2023 | Option Exercise | $1.50 | 446,668 | 670,002 | 446,668 | Feb 10, 2023, 09:47 PM |
| SCARLETT JOHN A | Chairman, President and CEO | Feb 08, 2023 | Sale | $3.08 | 446,666 | 1,375,731 | 0 | Feb 10, 2023, 09:47 PM |
| SCARLETT JOHN A | Chairman, President and CEO | Feb 10, 2023 | Sale | $3.00 | 446,668 | 1,340,004 | 0 | Feb 10, 2023, 09:47 PM |
| SCARLETT JOHN A | Chairman, President and CEO | Feb 09, 2023 | Sale | $3.03 | 446,666 | 1,353,398 | 0 | Feb 10, 2023, 09:47 PM |
| EASTHAM KARIN | Director | Jan 13, 2023 | Option Exercise | $1.10 | 35,000 | 38,500 | 109,047 | Jan 17, 2023, 07:01 PM |
| Kapur Anil | EVP, Corp Strategy & CCO | Dec 30, 2022 | Option Exercise | $1.11 | 6,021 | 6,683 | 53,216 | Jan 03, 2023, 08:55 PM |
| GRETHLEIN ANDREW J | EVP, Chief Operating Officer | Sep 12, 2022 | Option Exercise | $1.70 | 234,719 | 399,022 | 234,719 | Sep 14, 2022, 05:47 PM |
| Kapur Anil | EVP, Corp Strategy & CCO | Jun 30, 2022 | Option Exercise | $1.11 | 13,062 | 14,499 | 47,195 | Jul 01, 2022, 09:25 PM |
| EASTHAM KARIN | Director | Apr 20, 2022 | Option Exercise | $1.41 | 35,000 | 49,350 | 74,047 | Apr 21, 2022, 08:09 PM |
| O'Farrell Elizabeth G. | Director | Aug 21, 2020 | Buy | $1.73 | 17,441 | 30,173 | 19,641 | Aug 24, 2020, 08:57 PM |
| O'Farrell Elizabeth G. | Director | Jan 10, 2020 | Buy | $1.34 | 2,200 | 2,948 | 2,200 | Jan 13, 2020, 09:10 PM |
| O'Farrell Elizabeth G. | Director | Jan 10, 2020 | Buy | $1.35 | 800 | 1,080 | 800 | Jan 13, 2020, 09:10 PM |
| BEHRS MELISSA KELLY | EVP, Chief Business Officer | Apr 09, 2019 | Sale | $2.00 | 120,635 | 241,270 | 0 | Apr 10, 2019, 07:45 PM |
| Spiegel Robert J. | Director | Sep 13, 2018 | Option Exercise | $2.95 | 175,000 | 516,550 | 110,576 | Sep 13, 2018, 09:28 PM |
| Spiegel Robert J. | Director | Sep 13, 2018 | Sale | $6.85 | 175,000 | 1,198,750 | 65,576 | Sep 13, 2018, 09:28 PM |
| ROSENFIELD STEPHEN | EVP, Genl Counsel & Secretary | Aug 24, 2018 | Option Exercise | $1.89 | 1,362,250 | 2,572,745 | 425,000 | Aug 24, 2018, 09:32 PM |
| ROSENFIELD STEPHEN | EVP, Genl Counsel & Secretary | Aug 24, 2018 | Sale | $4.51 | 1,362,250 | 6,143,748 | 0 | Aug 24, 2018, 09:32 PM |
| Bloom Olivia Kyusuk | EVP, Chief Financial Officer | May 29, 2015 | Sale | $3.84 | 2,380 | 9,139 | 74,588 | Jun 01, 2015, 09:12 PM |
| BEHRS MELISSA KELLY | EVP BD and Port&Alliance Mgmt | May 29, 2015 | Sale | $3.84 | 2,380 | 9,139 | 120,635 | Jun 01, 2015, 09:12 PM |
| Hofstaetter Thomas | Director | Mar 18, 2015 | Option Exercise | $1.25 | 70,000 | 87,850 | 96,564 | Mar 19, 2015, 07:27 PM |
| Hofstaetter Thomas | Director | Mar 18, 2015 | Sale | $4.10 | 70,000 | 287,000 | 26,564 | Mar 19, 2015, 07:27 PM |
| Bloom Olivia Kyusuk | EVP, Chief Financial Officer | May 29, 2014 | Sale | $2.10 | 3,379 | 7,096 | 81,968 | May 30, 2014, 08:56 PM |
| BEHRS MELISSA KELLY | EVP Portfolio & Alliance Mgmt | May 29, 2014 | Sale | $2.10 | 4,826 | 10,135 | 143,015 | May 30, 2014, 08:50 PM |
| BRADBURY DANIEL | Director | May 09, 2014 | Buy | $1.75 | 142,776 | 249,858 | 142,776 | May 12, 2014, 07:45 PM |
| Bloom Olivia Kyusuk | EVP, Chief Financial Officer | Apr 01, 2014 | Sale | $2.13 | 7,435 | 15,837 | 85,347 | Apr 02, 2014, 06:11 PM |
| BEHRS MELISSA KELLY | EVP Portfolio & Alliance Mgmt | Apr 01, 2014 | Sale | $2.13 | 12,310 | 26,220 | 147,841 | Apr 02, 2014, 06:07 PM |
| SCARLETT JOHN A | President and CEO | Apr 01, 2013 | Buy | $1.03 | 50,000 | 51,500 | 125,000 | Apr 01, 2013, 09:46 PM |
| BEHRS MELISSA KELLY | SVP Alliance and Prog Mgmt | Jan 17, 2013 | Sale | $1.65 | 28,292 | 46,569 | 0 | Jan 22, 2013, 08:12 PM |
| Kelsey Stephen Michael | EVP, R&D Head, CMO | May 30, 2012 | Sale | $1.37 | 9,300 | 12,741 | 473,122 | Jun 01, 2012, 08:15 PM |
| EARP DAVID | SVP, Corp Transactions | May 30, 2012 | Sale | $1.37 | 27,155 | 37,202 | 467,406 | Jun 01, 2012, 08:15 PM |
| Bloom Olivia Kyusuk | VP, Chief Acctg Officer | May 30, 2012 | Sale | $1.37 | 11,029 | 15,110 | 147,782 | Jun 01, 2012, 08:14 PM |
| BEHRS MELISSA KELLY | SVP Strategic Portfolio Mgmt | May 30, 2012 | Sale | $1.37 | 18,910 | 25,907 | 405,151 | Jun 01, 2012, 08:14 PM |
| SCARLETT JOHN A | President and CEO | Jan 24, 2012 | Buy | $1.72 | 75,000 | 129,000 | 75,000 | Feb 08, 2012, 08:29 PM |
| SCARLETT JOHN A | President and CEO | Jan 24, 2012 | Option Exercise | $1.72 | 75,000 | 129,000 | 75,000 | Jan 25, 2012, 05:42 PM |
| KILEY THOMAS | Director | Nov 22, 2011 | Buy | $1.56 | 64,275 | 100,269 | 314,059 | Nov 23, 2011, 06:51 PM |
| KILEY THOMAS | Director | Oct 05, 2011 | Buy | $2.03 | 50,000 | 101,500 | 96,653 | Oct 06, 2011, 08:35 PM |
| Spink Katharine E. | SVP Alliance Mgmt & Operations | Jun 14, 2011 | Sale | $4.28 | 22,591 | 96,689 | 328,561 | Jun 16, 2011, 09:06 PM |
| LEBKOWSKI JANE | SVP, Chief Scientific Officer | Jun 14, 2011 | Sale | $4.28 | 25,262 | 108,121 | 568,154 | Jun 16, 2011, 09:05 PM |
| Kelsey Stephen Michael | EVP, R&D Head, CMO | Jun 14, 2011 | Sale | $4.28 | 4,858 | 20,792 | 476,773 | Jun 16, 2011, 09:04 PM |
| BEHRS MELISSA KELLY | SVP Strategic Portfolio Mgmt | Jun 14, 2011 | Sale | $4.28 | 25,262 | 108,121 | 424,061 | Jun 16, 2011, 09:03 PM |
| GREENWOOD DAVID | President, Interim CEO, CFO | Jun 14, 2011 | Sale | $4.28 | 34,005 | 145,541 | 754,031 | Jun 16, 2011, 09:02 PM |
| EARP DAVID | Chief Legal Counsel | Jun 14, 2011 | Sale | $4.28 | 25,262 | 108,121 | 494,561 | Jun 16, 2011, 08:58 PM |
| Bloom Olivia Kyusuk | VP, Chief Acctg Officer | Jun 14, 2011 | Sale | $4.28 | 6,997 | 29,947 | 158,811 | Jun 16, 2011, 08:57 PM |
| Bloom Olivia Kyusuk | VP, Chief Acctg Officer | May 24, 2011 | Sale | $4.47 | 1,200 | 5,364 | 165,808 | May 24, 2011, 09:41 PM |
| Spink Katharine E. | SVP Prgm Mgmt, Cell Therapies | May 24, 2011 | Sale | $4.47 | 419 | 1,873 | 351,152 | May 24, 2011, 09:40 PM |
| BEHRS MELISSA KELLY | SVP Strategic Portfolio Mgmt | May 24, 2011 | Sale | $4.47 | 2,975 | 13,298 | 449,323 | May 24, 2011, 09:40 PM |
| EARP DAVID | SVP Bus Dev, Chief Patnt Couns | May 24, 2011 | Sale | $4.47 | 2,975 | 13,298 | 519,823 | May 24, 2011, 09:39 PM |
| LEBKOWSKI JANE | SVP, Chief Scientific Officer | May 24, 2011 | Sale | $4.47 | 2,975 | 13,298 | 593,416 | May 24, 2011, 09:39 PM |
| GREENWOOD DAVID | President, Interim CEO, CFO | May 24, 2011 | Sale | $4.47 | 4,462 | 19,945 | 788,036 | May 24, 2011, 09:38 PM |
| Kelsey Stephen Michael | EVP, CMO, Oncology | May 05, 2011 | Sale | $4.83 | 14,163 | 68,407 | 364,131 | May 06, 2011, 08:09 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| O'Farrell Elizabeth G. | Director | 08/24/2023 | 15,064 |
| O'Farrell Elizabeth G. | Director | 08/24/2023 | 15,000 |
| Kapur Anil | EVP, Corp Strategy & CCO | 06/30/2023 | 15,437 |
| LAWLIS V BRYAN | Director | 05/11/2023 | 38,500 |
| LAWLIS V BRYAN | Director | 05/11/2023 | 105,000 |
| Molineaux Susan | Director | 05/01/2023 | 38,500 |
| Molineaux Susan | Director | 05/01/2023 | 86,800 |
| GRETHLEIN ANDREW J | EVP, Chief Operating Officer | 02/09/2023 | 226,500 |
| GRETHLEIN ANDREW J | EVP, Chief Operating Officer | 02/09/2023 | 1,165,699 |
| Bloom Olivia Kyusuk | EVP, Chief Financial Officer | 02/08/2023 | 604,000 |
| Bloom Olivia Kyusuk | EVP, Chief Financial Officer | 02/08/2023 | 1,232,000 |
| SCARLETT JOHN A | Chairman, President and CEO | 02/09/2023 | 669,999 |
| SCARLETT JOHN A | Chairman, President and CEO | 02/08/2023 | 669,999 |
| SCARLETT JOHN A | Chairman, President and CEO | 02/10/2023 | 670,002 |
| SCARLETT JOHN A | Chairman, President and CEO | 02/08/2023 | 1,375,731 |
| SCARLETT JOHN A | Chairman, President and CEO | 02/10/2023 | 1,340,004 |
| SCARLETT JOHN A | Chairman, President and CEO | 02/09/2023 | 1,353,398 |
| EASTHAM KARIN | Director | 01/13/2023 | 38,500 |
| Kapur Anil | EVP, Corp Strategy & CCO | 12/30/2022 | 6,683 |
| GRETHLEIN ANDREW J | EVP, Chief Operating Officer | 09/12/2022 | 399,022 |
| Kapur Anil | EVP, Corp Strategy & CCO | 06/30/2022 | 14,499 |
| EASTHAM KARIN | Director | 04/20/2022 | 49,350 |
| O'Farrell Elizabeth G. | Director | 08/21/2020 | 30,173 |
| O'Farrell Elizabeth G. | Director | 01/10/2020 | 2,948 |
| O'Farrell Elizabeth G. | Director | 01/10/2020 | 1,080 |
| BEHRS MELISSA KELLY | EVP, Chief Business Officer | 04/09/2019 | 241,270 |
| Spiegel Robert J. | Director | 09/13/2018 | 516,550 |
| Spiegel Robert J. | Director | 09/13/2018 | 1,198,750 |
| ROSENFIELD STEPHEN | EVP, Genl Counsel & Secretary | 08/24/2018 | 2,572,745 |
| ROSENFIELD STEPHEN | EVP, Genl Counsel & Secretary | 08/24/2018 | 6,143,748 |
| Bloom Olivia Kyusuk | EVP, Chief Financial Officer | 05/29/2015 | 9,139 |
| BEHRS MELISSA KELLY | EVP BD and Port&Alliance Mgmt | 05/29/2015 | 9,139 |
| Hofstaetter Thomas | Director | 03/18/2015 | 87,850 |
| Hofstaetter Thomas | Director | 03/18/2015 | 287,000 |
| Bloom Olivia Kyusuk | EVP, Chief Financial Officer | 05/29/2014 | 7,096 |
| BEHRS MELISSA KELLY | EVP Portfolio & Alliance Mgmt | 05/29/2014 | 10,135 |
| BRADBURY DANIEL | Director | 05/09/2014 | 249,858 |
| Bloom Olivia Kyusuk | EVP, Chief Financial Officer | 04/01/2014 | 15,837 |
| BEHRS MELISSA KELLY | EVP Portfolio & Alliance Mgmt | 04/01/2014 | 26,220 |
| SCARLETT JOHN A | President and CEO | 04/01/2013 | 51,500 |
| BEHRS MELISSA KELLY | SVP Alliance and Prog Mgmt | 01/17/2013 | 46,569 |
| Kelsey Stephen Michael | EVP, R&D Head, CMO | 05/30/2012 | 12,741 |
| EARP DAVID | SVP, Corp Transactions | 05/30/2012 | 37,202 |
| Bloom Olivia Kyusuk | VP, Chief Acctg Officer | 05/30/2012 | 15,110 |
| BEHRS MELISSA KELLY | SVP Strategic Portfolio Mgmt | 05/30/2012 | 25,907 |
| SCARLETT JOHN A | President and CEO | 01/24/2012 | 129,000 |
| SCARLETT JOHN A | President and CEO | 01/24/2012 | 129,000 |
| KILEY THOMAS | Director | 11/22/2011 | 100,269 |
| KILEY THOMAS | Director | 10/05/2011 | 101,500 |
| Spink Katharine E. | SVP Alliance Mgmt & Operations | 06/14/2011 | 96,689 |
| LEBKOWSKI JANE | SVP, Chief Scientific Officer | 06/14/2011 | 108,121 |
| Kelsey Stephen Michael | EVP, R&D Head, CMO | 06/14/2011 | 20,792 |
| BEHRS MELISSA KELLY | SVP Strategic Portfolio Mgmt | 06/14/2011 | 108,121 |
| GREENWOOD DAVID | President, Interim CEO, CFO | 06/14/2011 | 145,541 |
| EARP DAVID | Chief Legal Counsel | 06/14/2011 | 108,121 |
| Bloom Olivia Kyusuk | VP, Chief Acctg Officer | 06/14/2011 | 29,947 |
| Bloom Olivia Kyusuk | VP, Chief Acctg Officer | 05/24/2011 | 5,364 |
| Spink Katharine E. | SVP Prgm Mgmt, Cell Therapies | 05/24/2011 | 1,873 |
| BEHRS MELISSA KELLY | SVP Strategic Portfolio Mgmt | 05/24/2011 | 13,298 |
| EARP DAVID | SVP Bus Dev, Chief Patnt Couns | 05/24/2011 | 13,298 |
| LEBKOWSKI JANE | SVP, Chief Scientific Officer | 05/24/2011 | 13,298 |
| GREENWOOD DAVID | President, Interim CEO, CFO | 05/24/2011 | 19,945 |
| Kelsey Stephen Michael | EVP, CMO, Oncology | 05/05/2011 | 68,407 |
Load More Insider Transactions
FUNDS WITH A POSITION IN GERON CORP.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 46,202,425 | 1.96% | No change | Other |
| BLACKROCK INC. | 41,414,578 | 0.00318% | -1.8% | Other |
| VIVO CAPITAL, LLC | 27,225,292 | 7.06% | 12.76% | Other |
| ORBIMED ADVISORS LLC | 12,893,611 | 0.78% | 2558.48% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 11,425,985 | 0.00349% | 4.41% | Other |
| FARALLON CAPITAL MANAGEMENT LLC | 7,495,000 | 0.11% | New | Event Driven, Value |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 7,200,000 | 0.04% | New | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 3,138,567 | 0.02% | New | Event Driven |
| ALPS ADVISORS INC | 385,154 | 0.009% | 7.35% | Other |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 35,675 | 0.00139% | Exited | Other |
| AQR CAPITAL MANAGEMENT LLC | 29,992 | 0.00012% | Exited | Other |
CHANGE IN SHARES OUTSTANDING FOR GERON CORP.
STOCK BUYBACKS FOR GERON CORP.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
1.39%
1Q
09/30/2023
4.14%
2Q
06/30/2023
10.27%
3Q
03/31/2023
10.84%
4Q
12/31/2022
58.33%
5Q
09/30/2022
48.92%
6Q
06/30/2022
49.43%
7Q
03/31/2022
81.74%
8Q
12/31/2021
82.40%
9Q
09/30/2021
83.47%
10Q
06/30/2021
84.54%
11Q
03/31/2021
86.47%
12Q
12/31/2020
89.09%
13Q
09/30/2020
89.30%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR GERON CORP.
LOADING...